Autoimmune drug may help prevent kidney disease caused by diabetes

Abatacept protects kidney health of diabetic mice

2014-03-27

(Press-News.org) Washington, DC (March 27, 2014) — A drug currently used to treat autoimmune disease may also help prevent the kidney-damaging effects of diabetes, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). The findings suggest that clinical trials should be designed to test the drug in diabetic patients.

Kidney disease is one of the most serious complications of diabetes. Diabetics who develop kidney disease, or diabetic nephropathy, due to high blood glucose levels may eventually require dialysis or a kidney transplant.

Paolo Fiorina, MD, PhD (Boston Children's Hospital/Harvard Medical School) and his colleagues have discovered that a receptor called B7-1 is expressed by kidney cells during the progression of diabetic nephropathy. Furthermore, targeting this receptor with an available drug called CTLA4-Ig, or abatacept, helped to maintain kidney function in mice with diabetic nephropathy. Abatacept is currently being used to treat autoimmune disease due to its ability to target B7-1 expressed on immune cells.

"The next steps will be to test anti-B7-1 drugs in individuals with diabetes and diabetic nephropathy to see if they can abrogate the progression of the disease in humans as well," said Dr. Fiorina.

INFORMATION: Highlights

A receptor called B7-1 is expressed by kidney cells during the progression of kidney disease in diabetic mice and humans. Targeting this receptor with an available drug called CTLA4-Ig, or abatacept, helps to maintain kidney function in mice.

Study co-authors include Andrea Vergani, MD, Roberto Bassi, MD, Monika A. Niewczas, MD, PhD, Mehmet M. Altintas, PhD, Marcus G. Pezzolesi, PhD, Francesca D' Addio, MD, PhD, Melissa Chin, Sara Tezza, Moufida Ben Nasr, PhD, Deborah Mattinzoli, Masami Ikehata, MD, Domenico Corradi, MD, Valerie Schumacher, PhD, Lisa, Buvall, PhD, Chih-Chuan Yu, Jer-Ming Chang, MD, Stefano La Rosa, MD, Giovanna Finzi, PhD, Anna Solini, MD, PhD, Flavio Vincenti, MD , Maria Pia Rastaldi, MD, PhD, Jochen Reiser, MD, PhD, Andrzej S. Krolewski, MD, PhD , Peter H. Mundel, MD, and Mohamed H. Sayegh, MD.

Disclosures: Jochen Reiser has pending or issued patents on novel kidney protective therapies, and he stands to receive royalties from their future commercialization. The other authors reported no financial disclosures.

The article, entitled "Role of Podocyte B7-1 in Diabetic Nephropathy," will appear online at http://jasn.asnjournals.org/ on March 27, 2014.

The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.

Founded in 1966, and with more than 14,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.

ELSE PRESS RELEASES FROM THIS DATE:

Major depression linked with nearly twice the risk of kidney failure in diabetics

2014-03-27

Washington, DC (March 27, 2014) — Major depression may increase diabetes patients' risk of developing kidney failure, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). Additional studies are needed to determine whether treatment for depression can improve kidney health in patients with diabetes. Individuals with diabetes have a high prevalence of depressive symptoms, which has previously been linked with negative health outcomes such as cardiovascular disease and premature death. Little is known ...

Gulf War illness not in veterans' heads, but in their mitochondria

2014-03-27

Researchers at the UC San Diego School of Medicine have demonstrated for the first time that veterans of the 1990-91 Persian Gulf War who suffer from "Gulf War illness" have impaired function of mitochondria – the energy powerhouses of cells. The findings, published in the March 27, 2014 issue of PLOS ONE, could help lead to new treatments benefitting affected individuals – and to new ways of protecting servicepersons (and civilians) from similar problems in the future, said principal investigator Beatrice A. Golomb MD, PhD, professor of medicine. Golomb, with associate ...

Stroke patients should receive customized palliative care

2014-03-27

People recovering from a stroke should have a well-coordinated medical team to personalize care, optimize quality of life and minimize suffering, according to a scientific statement published in the American Heart Association journal Stroke. The statement is the first in the United States to outline fundamental palliative care for stroke survivors. Palliative care is patient- and family-centered care that improves life by anticipating, preventing and treating suffering. "The majority of stroke patients need access to some form of palliative medicine," said Robert Holloway, ...

Consistent blood pressure control may cut rate of second stroke in half

2014-03-27

Stroke survivors who consistently control their blood pressure may reduce the likelihood of a second stroke by more than half, according to new research in the American Heart Association journal Stroke. For the study, researchers analyzed the results from the Vitamin Intervention for Stroke Prevention (VISP) trial, which enrolled 3,680 ischemic stroke patients ages 35 and older in 1996-2003. Ischemic strokes are caused by a clot or other blockage in a blood vessel supplying the brain. Participants had been tested for several risk factors, including blood pressure levels ...

US clean-air efforts stay on target

2014-03-27

HOUSTON – (March 27, 2014) – National efforts in the last decade to clear the air of dangerous particulate matter have been so successful that most urban areas have already attained the next benchmark, according to new research by Rice University. Atmospheric researchers at Rice studied the state implementation plans (SIPs) from 23 regions mandated by the Environmental Protection Agency to reduce particulate matter (PM) smaller than 2.5 microns (PM 2.5) to less than 15 micrograms per cubic meter by 2009. The Rice analysis appears this week in the Journal of the Air ...

Mechanical forces driving breast cancer lead to key molecular discovery

2014-03-27

The stiffening of breast tissue in breast-cancer development points to a new way to distinguish a type of breast cancer with a poor prognosis from a related, but often less deadly type, UC San Francisco researchers have found in a new study. The findings, published online March 16, 2014 in Nature Medicine, may lead eventually to new treatment focused not only on molecular targets within cancerous cells, but also on mechanical properties of surrounding tissue, the researchers said. In a mouse model of breast cancer, scientists led by Valerie Weaver, PhD, professor of ...

Notre Dame scientists develop largest developmental proteomic data set for any animal

2014-03-27

Now that the human genome is sequenced, University of Notre Dame researchers are focusing on the study of the proteome, which is the protein content of an organism, tissue or cell. Bioanalytical chemist Norman Dovichi and molecular biologist Paul Huber have successfully tracked the changing patterns of protein expression during early development of Xenopus laevis, or African clawed frog, embryos. They have developed the largest data set on developmental proteomics for any organism, and have included the single-cell zygote. Their research has uncovered an unexpected amount ...

The circadian clock is like an orchestra with many conductors

2014-03-27

ANN ARBOR—You've switched to the night shift and your weight skyrockets, or you wake at 7 a.m. on weekdays but sleep until noon on weekends—a social jet lag that can fog your Saturday and Sunday. Life runs on rhythms driven by circadian clocks, and disruption of these cycles is associated with serious physical and emotional problems, says Orie Shafer, a University of Michigan assistant professor of molecular, cellular and developmental biology. Now, new findings from Shafer and U-M doctoral student Zepeng Yao challenge the prevailing wisdom about how our body clocks ...

Scientists synthesize first functional 'designer' chromosome in yeast

2014-03-27

An international team of scientists led by Jef Boeke, PhD, director of NYU Langone Medical Center's Institute for Systems Genetics, has synthesized the first functional chromosome in yeast, an important step in the emerging field of synthetic biology, designing microorganisms to produce novel medicines, raw materials for food, and biofuels. Over the last five years, scientists have built bacterial chromosomes and viral DNA, but this is the first report of an entire eukaryotic chromosome, the threadlike structure that carries genes in the nucleus of all plant and animal ...

New way to filter light

2014-03-27

CAMBRIDGE, Mass-- Light waves can be defined by three fundamental characteristics: their color (or wavelength), polarization, and direction. While it has long been possible to selectively filter light according to its color or polarization, selectivity based on the direction of propagation has remained elusive. But now, for the first time, MIT researchers have produced a system that allows light of any color to pass through only if it is coming from one specific angle; the technique reflects all light coming from other directions. This new approach could ultimately lead ...

LAST 30 PRESS RELEASES:

New tablet shows promise for the control and elimination of intestinal worms

Project to redesign clinical trials for neurologic conditions for underserved populations funded with $2.9M grant to UTHealth Houston

Menarini Group and Insilico Medicine enter a second exclusive global license agreement for an AI discovered preclinical asset targeting high unmet needs in oncology

Climate fee on food could effectively cut greenhouse gas emissions in agriculture while ensuring a social balance

Harnessing microwave flow reaction to convert biomass into useful sugars

[Press-News.org] Autoimmune drug may help prevent kidney disease caused by diabetes
Abatacept protects kidney health of diabetic mice